igf-1 lr3 ben greenfield The Science of Biohacking, Longevity, and Human Performance | - The Secretary Kennedy Podcast The Fascinating Interplay between Growth
Description
P., & Fridovich, I
Four injections over 20 days is a substantially lower frequency than any daily peptide protocol
ALT: 62
In a review published last year, Sikiric and his colleagues describe BPC-157 as a drug like no other: In animal models, it counteracts symptoms akin to those of Parkinsons, Alzheimers, and schizophrenia
